Zagros Darou Pharmaceutical and Feed Company (DEZAGROS) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- DEZAGROS
- Industry
- Pharmaceuticals
- Market
- Iran Fara Bourse
Latest periods
| Item | To 1405/06/31 | To 1404/06/31 | To 1403/06/31 | To 1402/06/31 |
|---|---|---|---|---|
| Operating revenue | 71,239,811 | 17,976,208 | 12,009,512 | 9,466,178 |
| Cost of operating revenue | -28,373,528 | -6,853,716 | -4,109,661 | -4,470,640 |
| Gross profit (loss) | 42,866,283 | 11,122,492 | 7,899,851 | 4,995,538 |
| Selling, general and administrative expenses | -1,648,375 | -674,783 | -427,372 | -246,148 |
| Other expenses | -24,766 | 0 | 0 | -168,225 |
| Operating profit (loss) | 41,193,142 | 10,447,709 | 7,472,479 | 4,581,165 |
| Finance costs | -3,212,500 | -1,959,872 | -1,718,217 | -1,072,788 |
| Other non-operating income and expenses | 462,874 | 10,180 | 15,952 | 5,730 |
| Profit (loss) from continuing operations before tax | 38,443,516 | 8,498,017 | 5,770,214 | 3,514,107 |
| Current year tax | -1,868,860 | -845,803 | -580,801 | -366,594 |
| Net profit (loss) from continuing operations | 36,574,656 | 7,652,214 | 5,189,413 | 3,147,513 |
| Net profit (loss) | 36,574,656 | 7,652,214 | 5,189,413 | 3,147,513 |
| Basic earnings (loss) per share | 4,750 rials | 4,501 rials | 3,053 rials | 0 rials |
| Net earnings (loss) per share, rials | 4,750 rials | 4,502 rials | 3,053 rials | 1,852 rials |
| Capital | 7,700,000 | 1,700,000 | 1,700,000 | 1,700,000 |
Reporting periods
24 periods are on file for this report, from the period ending 1397/12/29 to the period ending 1405/06/31.